| Name | GCN2-IN-1 | 
|---|---|
| Synonyms | 
                                
                                MFCD30345302
                                
                                
                                 3-(1H-Indazol-6-yl)-N-[1-(tetrahydro-2H-pyran-4-yl)-1H-pyrazol-4-yl]-3H-[1,2,3]triazolo[4,5-d]pyrimidin-5-amine 3H-1,2,3-Triazolo[4,5-d]pyrimidin-5-amine, 3-(1H-indazol-6-yl)-N-[1-(tetrahydro-2H-pyran-4-yl)-1H-pyrazol-4-yl]-  | 
                        
| Description | GCN2-IN-1 is a potent general control nonderepressible 2 kinase (GCN2) inhibitor with IC50s of <0.3 μM in the enzyme and cell assay. | 
|---|---|
| Related Catalog | |
| Target | 
                                
                                 IC50: <0.3 μM (GCN2)[1]  | 
                        
| In Vitro | GCN2-IN-1 (Compound A-92) is a GCN2 inhibitor, which may be useful as a chemotherapeutic drug for the treatment of cancer[1]. | 
| References | 
| Density | 1.7±0.1 g/cm3 | 
|---|---|
| Boiling Point | 760.0±70.0 °C at 760 mmHg | 
| Molecular Formula | C19H18N10O | 
| Molecular Weight | 402.413 | 
| Flash Point | 413.4±35.7 °C | 
| Exact Mass | 402.166504 | 
| LogP | 0.87 | 
| Vapour Pressure | 0.0±2.6 mmHg at 25°C | 
| Index of Refraction | 1.902 | 
| Storage condition | -20℃ |